Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 May 8;14(5):445. doi: 10.3390/ph14050445

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Hazard ratios for overall survival (a) and progression-free survival (b) by antibiotic days of therapy (DOT). Each control refers to the patients who have not used antibiotics (NoABX). Anti-tuberculosis medications, beta-lactamase inhibitors, carbapenem (meropenem), second-generation cephalosporins, fourth-generation cephalosporin (cefepime), glycopeptides, imidazole (metronidazole), macrolides, sulfamethoxazole/trimethoprim and tetracycline (doxycycline) were not included in this forest plot due to small sample sizes (<5). Abbreviations: No., number; PD, progression of disease.

Hazard ratios for overall survival (a) and progression-free survival (b) by antibiotic days of therapy (DOT). Each control refers to the patients who have not used antibiotics (NoABX). Anti-tuberculosis medications, beta-lactamase inhibitors, carbapenem (meropenem), second-generation cephalosporins, fourth-generation cephalosporin (cefepime), glycopeptides, imidazole (metronidazole), macrolides, sulfamethoxazole/trimethoprim and tetracycline (doxycycline) were not included in this forest plot due to small sample sizes (<5). Abbreviations: No., number; PD, progression of disease.